Infectious disease poses a threat to human health and is becoming more dangerous with increasing urbanization, population growth, and climate change. Fortunately, genomic sequencing technologies have reached a point where pathogens can be characterized more quickly and comprehensively than ever before. Still, obstacles to this endeavor remain, as many sequencing technologies are restricted to well-funded centralized laboratories, owing to cost and infrastructure constraints. Oxford Nanopore sequencing aims to break these barriers, delivering comprehensive, affordable real-time analysis of human and animal pathogens.
Download this white paper to learn how nanopore sequencing can be a useful tool for both infectious disease research and genomic surveillance.
